Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-24

Clinical Trial Update: Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial is investigating the efficacy of melatonin, low-dose quetiapine, and placebo in patients with psychiatric disorders and insomnia. It is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)
  • Quetiapine (quetiapine)

Snippet

Sponsor: Lone Baandrup | Conditions: Psychiatric Disorders, Insomnia | Phase 2, Phase 3 | Status: RECRUITING